Department of Persian Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Department of Pediatrics, Shiraz University of Medical Sciences, Shiraz, Iran.
Curr Drug Discov Technol. 2020;17(5):696-703. doi: 10.2174/1570163816666190620142256.
Finding non-systemic antipyretic option in cancer patients who simultaneously receive several other drugs seems be logical. This study was designed to evaluate complementary therapy with Viola odorata L. oil for fever control in febrile neutropenic children.
In a randomized placebo controlled clinical trial, 41 febrile children were divided into two groups. Children in the active drug group received viola oil (20 drops) to be rubbed on the peripheral margin of the patient umbilicus. Primary outcome measure of the study was the mean axillary temperature in the 30, 60, and 240 minutes after the intervention.
The mean temperature reduced significantly in the viola group after 30 minutes of administration (p =0.005), while there was no significant change in the placebo group (p =1.00). The number of patients who received paracetamol as the rescue treatment was significantly lower in the viola group than that in the placebo group (5 vs. 17, p =0.001).
The results of our study showed the safety and efficacy of complementary therapy with Viola odorata L. oil for fever control in febrile neutropenic children during hospital course.
在同时接受多种其他药物治疗的癌症患者中寻找非系统性退热选择似乎是合理的。本研究旨在评估用堇菜属植物油进行补充治疗以控制发热性中性粒细胞减少症儿童发热的效果。
在一项随机安慰剂对照临床试验中,将 41 名发热儿童分为两组。在活性药物组中,患儿接受堇菜属植物油(20 滴)涂于患者脐周外周缘。本研究的主要观察指标是干预后 30、60 和 240 分钟时的腋温平均值。
给药后 30 分钟,堇菜属植物组的平均体温明显下降(p =0.005),而安慰剂组无明显变化(p =1.00)。与安慰剂组相比,堇菜属植物组接受扑热息痛作为抢救治疗的患者人数明显减少(5 例 vs. 17 例,p =0.001)。
我们的研究结果表明,在住院期间,堇菜属植物油补充治疗对发热性中性粒细胞减少症儿童的发热控制安全且有效。